Clinical Trials Directory

Trials / Completed

CompletedNCT03379181

Thermogenesis in Hyperthyroidism and Effect of Anti-Adrenergic Therapy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
19 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The overall objective of the HEAT study is to determine the acute effect of propranolol on energy expenditure in patients suffering from hyperthyroidism and to evaluate the consequences of the change of hyper- to euthyroidism on metabolism during the course of treatment, especially with regard to the reaction to cold ambient temperatures.

Conditions

Interventions

TypeNameDescription
DRUGPropranololPatients receive a single dose of 80 mg propranolol p.o.

Timeline

Start date
2017-07-18
Primary completion
2020-02-12
Completion
2020-02-12
First posted
2017-12-20
Last updated
2020-02-13

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT03379181. Inclusion in this directory is not an endorsement.